Corbus Pharmaceuticals

CRBP • NASDAQ • Stock Fundamentals

Corbus Pharmaceuticals is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Yuval Cohen, with a market cap of $146.6M.

Market Cap$146.6M

Employees19.0

CEOYuval Cohen

CountryUnited States of America

Healthcare

Biotechnology

Most Recent EarningsMay 12, 2026 · 16 days agoQ1 2026

Next EarningsAug 11, 2026 · in 2 monthsBefore Market Open · Q2 2026

Financials

Based on Q1 2026 filing

Common questions about Corbus Pharmaceuticals

Corbus Pharmaceuticals (CRBP) has a market capitalization of $146.6M and trades on NASDAQ.

Corbus Pharmaceuticals has approximately 19 employees.